Jeffrey I. Everitt

Duke University — United States

Veterinary · Health Sciences

47h-index9.6kcitations338works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Animal testing and alternatives(31), Radiomics and Machine Learning in Medical Imaging(30), Carcinogens and Genotoxicity Assessment(29), Renal and related cancers(24), Occupational and environmental lung diseases(23)

Publications338 total

SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formation
UNC Libraries·2026Open Access
Abstract B030: Programmable mRNA 3′UTR engineering restores MHC-I and overcomes immune evasion in prostate cancer
Cancer Immunology Research·2026
Talc fits the framework of poorly soluble low-toxicity particles - implications for hazard classification
Regulatory Toxicology and Pharmacology·2026
Supplementary figure FS3 from Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma
2025Open Access
Supplementary figure FS1 from Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma
2025Open Access
Supplementary figure FS2 from Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma
2025Open Access
Supplementary figure FS4 from Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma
2025Open Access
Supplementary table TS1 from Neoadjuvant Radiation Therapy and Surgery Improves Metastasis-Free Survival over Surgery Alone in a Primary Mouse Model of Soft Tissue Sarcoma
2025Open Access
Pathology as a Core Discipline in the Biological Evaluation of Medical Devices
International Journal of Toxicology·2025
Optimization of the Nonclinical Biological Evaluation of Medical Devices Using Toxicologic Pathology Best Practices
Advanced Healthcare Materials·2025Open Access
Supplementary figure 7 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary Table 1 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary figure 3 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary Table 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary figure 2 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary figure 4 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Data from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary Materials & Methods1 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary figure 5 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
Supplementary figure 6 from Nrf2 Hyperactivation as a Driver of Radiotherapy Resistance and Suppressed Antitumor Immunity in Head and Neck Squamous Cell Carcinoma
2025Open Access
page 1 of 17Next →

Frequent Co-authors

Cheryl L. Walker(6), Douglas C. Wolf(5), Thomas L. Goldsworthy(4), S R Howe(3), Mark J. Walker(3), Cheryl L. Walker(3), Cheryl L. Walker(3), Vuokko L. Kinnula(3), James D. Crapo(3), Pakawat Chongsathidkiet(2), Xiuyu Cui(2), S. Harrison Farber(2), Karolina Woroniecka(2), Aladine A. Elsamadicy(2), Hanna Kemeny(2), Luis Sánchez-Pérez(2), Peter E. Fecci(2), Edilberto Bermudez(2), James B. Mangum(2), Brian A. Wong(2)